Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats
Authors:
- Kevin G. MurphyKMKevin G. Murphy
- Michael PattersonMPMichael Patterson
- Gavin A. BewickGBGavin A. Bewick
- Gordon W. H. StampGSGordon W. H. Stamp
- Annette E. CurtisACAnnette E. Curtis
- Jennifer H. CookeJCJennifer H. Cooke
- Preeti H. JethwaPJPreeti H. Jethwa
- Jeannie F. ToddJTJeannie F. Todd
- Mohammad A. GhateiMGMohammad A. Ghatei
- Stephen R. BloomSBStephen R. Bloom
- 1 November 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 291 (5) , E1074-E1082
Abstract
The kisspeptins are KiSS-1 gene-derived peptides that signal through the G protein-coupled receptor-54 (GPR54) and have recently been shown to be critical regulators of reproduction. Acute intracerebroventricular or peripheral administration of kisspeptin stimulates the hypothalamic-pituitary-gonadal (HPG) axis. This effect is thought to be mediated via the hypothalamic gonadotropin-releasing hormone (GnRH) system. Chronic administration of GnRH agonists paradoxically suppresses the HPG axis after an initial agonistic stimulation. We investigated the effects of continuous peripheral kisspeptin administration in male rats by use of Alzet minipumps. Initially we compared the effects of acute subcutaneous administration of kisspeptin-10, -14, and -54 on the HPG axis. Kisspeptin-54 produced the greatest increase in plasma LH and total testosterone at 60 min postinjection and was used in the subsequent continuous administration experiments. Chronic subcutaneous long-term administration of 50 nmol kisspeptin-54/day for 13 days decreased testicular weight. Histological examination showed degeneration of the seminiferous tubules associated with a significant decrease in the circulating levels of the testes-derived hormone, inhibin B. Plasma free and total testosterone were also lower, although these changes did not reach statistical significance. Further studies examined the effects of shorter periods of continuous kisspeptin administration. Subcutaneous administration of 50 nmol kisspeptin-54 for 1 day increased plasma LH and testosterone. This effect was lost after 2 days of administration, suggesting a downregulation of the HPG axis response to kisspeptin following continuous administration. These findings indicate that kisspeptin may provide a novel tool for the manipulation of the HPG axis and spermatogenesis.Keywords
This publication has 42 references indexed in Scilit:
- Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human MalesThe Journal of Clinical Endocrinology & Metabolism, 2005
- Changes in Hypothalamic KiSS-1 System and Restoration of Pubertal Activation of the Reproductive Axis by Kisspeptin in UndernutritionEndocrinology, 2005
- DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONSAnnual Review of Neuroscience, 2004
- The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive systemBiochemical and Biophysical Research Communications, 2003
- Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Proceedings of the National Academy of Sciences, 2003
- Effects of Acute Graded Reductions in Testicular Blood Flow on Testicular Morphology in the Adult Rat1Biology of Reproduction, 2001
- Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.Journal of Clinical Investigation, 1998
- Rapid desensitization of GnRH-stimulated intracellular signalling events in alpha T3-1 and HEK-293 cells expressing the GnRH receptor.Endocrinology, 1995
- GONADOTROPIN-RELEASING HORMONE AND ITS ANALOGSAnnual Review of Medicine, 1994
- Gonadotropin-Releasing Hormone and Its Agonist Inhibit Testicular Luteinizing Hormone Receptor and Steroidogenesis in Immature and Adult Hypophysectomized Rats*Endocrinology, 1980